BCMA/CD70-targeted CAR-T therapy

· Chongqing Precision Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCMA/CD70-targeted CAR-T therapy, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases [Phase 1]